Global Panic Disorders Market Size To Exceed USD 15.42 Billion By 2033 | CAGR of 4.73%
Category: HealthcareGlobal Panic Disorders Market Size To Exceed USD 15.42 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Panic Disorders Market Size is to grow from USD 9.71 Billion in 2023 to USD 15.42 Billion by 2033, at a CAGR of 4.73% during the projected period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the "Global Panic Disorders Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Psychotherapy, Medication, and Others), By Dosage Form (Tablets, Injections, and Others), By End-User (Hospitals & Clinics and Mental Healthcare Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/panic-disorders-market
People who suffer from panic disorder usually undergo sudden, unprovoked panic attacks. These attacks are marked by a sudden wave of panic, discomfort, or a feeling of losing control, even in circumstances where there doesn't seem to be an obvious risk or reason. Not every person who has a panic attack goes on to have panic disorder. Often, panic disorders begin in the late teenage years or early adulthood. Women have panic disorders at a higher rate than males experience. Panic disorders can manifest as sensations of impending dread or danger, sweating, chills, nausea, headaches, chest pain, rapid heartbeat, and tingling or numbness. The prevalence of mental and anxiety disorders is expected to rise, knowledge of these diseases is expected to grow, and the availability of efficient treatment options is one of the main factors expected to fuel the expansion of panic disorders. Moreover, the market's growth can be expedited by the leading corporations' enhanced efforts to promote consumer perception. However, an important barrier to market expansion is the stigma associated with mental health issues like panic disorders. Cultural challenges discrimination, and misconceptions that often prevent people from accessing prompt medical care and diagnosis are barriers to the growth of the healthcare industry. Financial limitations, a deficient infrastructure, and a shortage of mental health professionals can all hamper the diagnosis and treatment of panic disorders.
The medication segment dominates the market with the largest revenue share through the predicted timeframe.
Based on treatment type, the global panic disorders market is segmented into psychotherapy, medication, and others. Among these, the medication segment dominates the market with the largest revenue share through the predicted timeframe. Serotonin & norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, and other drugs that relieve depressive symptoms including irritability and sadness are among the pharmaceuticals used to treat panic disorder. Therefore, to reduce the number of panic disorder instances, more people are purchasing medication for panic disorders due to the benefits of the medication mentioned above.
The tablets segment dominates the global panic disorders market over the predicted timeframe.
Based on the dosage form, the global panic disorders market is segmented into tablets, injections, and others. Among these, the tablets segment dominates the global panic disorders market over the predicted timeframe. The primary advantages of the tablet form of panic disorder include reduced variability, unit dose, excellent precision, and other advantages. Furthermore, panic disorder tablets are simpler to swallow, and, in certain situations, they dissolve well in water when given to a young patient.
The hospitals & clinics segment dominates the global panic disorders market during the predicted timeframe.
Based on the end-user, the global panic disorders market is segmented into hospitals & clinics and mental healthcare centers. Among these, the hospitals & clinics segment dominates the global panic disorders market during the predicted timeframe. To lessen the frequency and intensity of panic disorder and enhance everyday functioning, hospitals and clinics are increasingly using treatments for panic disorders, such as medication and psychotherapy. As a result, the market's rise is being aided by hospitals' increasing adoption of panic disorder therapies.
North America dominates the market with the highest market share during the forecast period.
Get more details on this report -
North America dominates the market with the highest market share during the forecast period. This region's rapid progress can be attributed to several factors, including the large number of industry participants and the increasing awareness among consumers of the availability of effective therapies for panic disorders. Additionally, the opening of new treatment facilities for panic disorders, collaborations between pharmaceutical companies and other key players, clinical trials linked to the treatment of panic disorders to obtain FDA approval, and other factors all contribute to the growing use of treatments for panic disorders to prevent panic disorders. These factors drive the growth of the panic disorders market during the forecast period.
Asia-Pacific region is expected to grow rapidly during the forecast period. Several numerous possibilities that the main companies have yet to capture, and this sector is expanding quickly. Moreover, market expansion is expected to be fueled by the increasing spending power of local consumers. The existence of generic manufacturing sectors and the expansion of healthcare facilities in the Asia Pacific area are two other elements that are anticipated to support market expansion revenue during the anticipated timeframe. These factors drive the expansion of the panic disorders market during the forecast period in the Asia Pacific region.
Major vendors in the global panic disorders market are Boehringer Ingelheim GmbH., F. Hoffmann-La Roche Ltd., Pfizer, Inc., Actavis Plc., Eli Lilly and Company, Mylan, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc., Valeant Pharmaceuticals International, Inc., H. Lundbeck A/S, Sanofi, Neurocrine Biosciences, Inc., AstraZeneca Plc., Bausch Health Companies Inc., and Other Key Players.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In March 2022, HMNC Brain Health's oral prolonged-release ketamine (KET01) formulation demonstrated encouraging top-line results from a Phase 2 Proof-of-Concept investigator-initiated trial in treating treatment-resistant depression (TRD).
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global panic disorders market based on the below-mentioned segments:
Global Panic Disorders Market, By Treatment Type
- Psychotherapy
- Medication
- Others
Global Panic Disorders Market, By Dosage Form
- Tablets
- Injections
- Others
Global Panic Disorders Market, By End-User
- Hospitals & Clinics
- Mental Healthcare Centers
Global Panic Disorders Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?